Evidence map›Paper›PMID 37173679›Full record

ReviewBMC endocrine disorders2023

A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature.

Danting Li, Yan Wang, Huiwen Tan, Peiqiong Luo, Yerong Yu

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in BMC endocrine disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Danting LiDivision of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Yan WangDivision of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Huiwen TanDivision of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China. huiwent2016@scu.edu.cn.ORCID http://orcid.org/0000-0002-0451-8283
Peiqiong LuoDivision of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Yerong YuDivision of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Sichuan University · CN

Funding

Sichuan Province Science and Technology Support Program No.2016SZ0058Sichuan Province Science and Technology Support Program No.23ZDYF2920
6 · The paper itself

Abstract

backgroundGiant prolactinoma (> 4 cm in dimension) is a rare disorder. Invasive macroprolactinoma has the potential to cause base of skull erosion and extend into the nasal cavity or even the sphenoid sinus. Nasal bleeding caused by intranasal tumor extension is a rare complication associated with invasive giant prolactinoma. We report a case of giant invasive macroprolactinoma with repeated nasal bleeding as the initial symptom. CASE PRESENTATION: A 24-year-old man with an invasive giant prolactinoma in the nasal cavity and sellar region who presented with nasal bleeding as the initial symptom, misdiagnosed as olfactory neuroblastoma. However, markedly elevated serum prolactin levels (4700 ng/mL), and a 7.8-cm invasive sellar mass confirmed the diagnosis of invasive giant prolactinoma. He was treated with oral bromocriptine. Serum prolactin was reduced to near normal after 6 months of treatment. Follow-up magnetic resonance imaging showed that the sellar lesion had disappeared completely and the skull base lesions were reduced.

conclusionThis case is notable in demonstrating the aggressive nature of untreated invasive giant prolactinomas which can cause a diagnostic difficulty with potential serious consequences. Early detection of hormonal levels can avoid unnecessary nasal biopsy. Early identification of pituitary adenoma with nasal bleeding as the first symptom is particularly important.

Indexed as

Pituitary NeoplasmsProlactinomaAdultBromocriptineEpistaxisHumansMagnetic Resonance ImagingMaleProlactinYoung AdultBromocriptineProlactinBromocriptineGiant macroprolactinomaInvasiveNasal bleedingPituitary adenoma

Identifiers

PMID37173679
PMCPMC10176701
OpenAlexW4376255570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.